Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Treatment for T-Cell ALL and NHL (POG 9404)
NCT01230983Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Jun 1996
- Primary completion
- Sep 2001
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of methotrexate, dexrazoxane in t-cell acute lymphoblastic leukemia (T-ALL), lymphoblastic lymphoma (LL), sponsored by Children's Oncology Group. Started Jun 1996; status: completed.
02
Drugs
methotrexatedexrazoxane
03
Conditions
t-cell acute lymphoblastic leukemia (T-ALL)lymphoblastic lymphoma (LL)
Beyond the preview
Go deeper on NCT01230983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01230983.